Skip to main content
. 2022 Nov 18;41(1):193–200. doi: 10.1016/j.vaccine.2022.11.020

Table 3.

Inhaled medications taken by chronic obstructive pulmonary disease patients in unvaccinated, once vaccinated and double vaccinated groups.

Unvaccinated
Once vaccinated
Double vaccinated
Total
Medication (n, %) 172 % 31 % 1308 % 1511 % p-value
SABA 147 85.47 26 83.87 1022 78.13 1173 77.63 0.030
LAMA 14 8.14 1 3.23 146 11.16 161 10.66 0.086
LABA 3 1.74 1 3.23 56 4.28 60 3.97 0.130
LABA and LAMA 46 26.74 9 29.03 411 31.42 466 30.84 0.236
ICS and LABA 27 15.70 7 22.58 131 10.02 165 10.92 0.003
LABA and LAMA and ICS 79 45.93 13 41.94 525 40.14 617 40.83 0.172
Rare combination 3 1.74 0 0.00 27 2.06 30 1.99 0.409
No data available 0 0.00 0 0.00 12 0.92 12 0.79 0.202

Data are presented as frequency and percentage; SABA: short-acting bronchodilators; LABA: long-acting bronchodilators; LAMA: long-acting muscarinic antagonist; ICS: inhaled corticosteroids; p < 0.05 means the two indicators were significantly correlated;